or Try an Advanced Search...

    Technical Analysis for ADTX - ADiTx Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.32 -4.40% -0.01
    ADTX closed down 3.17 percent on Wednesday, November 20, 2024, on 21 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ADTX trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction -4.40%
    Narrow Range Bar Range Contraction -4.40%
    Wide Bands Range Expansion -4.40%
    Oversold Stochastic Weakness -4.40%
    Narrow Range Bar Range Contraction -7.43%
    Wide Bands Range Expansion -7.43%
    Oversold Stochastic Weakness -7.43%
    Narrow Range Bar Range Contraction -4.42%
    New 52 Week Low Weakness -4.42%
    Wide Bands Range Expansion -4.42%
    Older End-of-Day Signals for ADTX ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 2 hours ago
    Down 3% about 2 hours ago
    Fell Below Previous Day's Low about 2 hours ago
    Down 2 % about 2 hours ago
    Down 1% about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ADTX Chart by TradingView
    Basic chart:

    Profile

    Aditx Therapeutics, Inc., is developing technologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring. The immune reprogramming technology is currently at the pre-clinical stage and is designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted organs, autoimmune diseases, and allergies. The immune monitoring technology is designed to provide a personalized comprehensive profile of the immune system.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Immunology Immune System Immunotherapy Autoimmune Disease Autoimmunity Organs Allergies

    Is ADTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 19 Appili Therapeutics Announces Receipt of Final Court Order for Arrangement with Aditxt, Inc.
    Nov 14 Evofem Biosciences Announces Financial Results for the Third Quarter of 2024
    Nov 14 Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
    Nov 8 Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares
    Nov 7 Aditxt’s Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders
    Nov 6 Appili Therapeutics Announces Results of Special Meeting of Shareholders
    Nov 6 Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem
    Nov 6 Evofem Secures Investor Support for Proposed Merger through Voting Agreements
    Oct 31 Aditxt’s Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
    Oct 31 Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
    See more ADTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 380.0
    52 Week Low 0.31
    Average Volume 3,264,710
    200-Day Moving Average 65.97
    50-Day Moving Average 4.13
    20-Day Moving Average 0.48
    10-Day Moving Average 0.35
    Average True Range 0.31
    RSI (14) 9.91
    ADX 39.58
    +DI 15.26
    -DI 35.43
    Chandelier Exit (Long, 3 ATRs) 0.13
    Chandelier Exit (Short, 3 ATRs) 1.25
    Upper Bollinger Bands 0.78
    Lower Bollinger Band 0.17
    Percent B (%b) 0.28
    BandWidth 129.51
    MACD Line -1.22
    MACD Signal Line -1.68
    MACD Histogram 0.457
    Fundamentals Value
    Market Cap 564.34 Thousand
    Num Shares 1.67 Million
    EPS -12.00
    Price-to-Earnings (P/E) Ratio -0.03
    Price-to-Sales 8.56
    Price-to-Book 0.38
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.38
    Resistance 3 (R3) 0.38 0.36 0.37
    Resistance 2 (R2) 0.36 0.35 0.36 0.37
    Resistance 1 (R1) 0.35 0.35 0.34 0.35 0.37
    Pivot Point 0.34 0.34 0.33 0.34 0.34
    Support 1 (S1) 0.33 0.33 0.32 0.33 0.31
    Support 2 (S2) 0.31 0.32 0.31 0.31
    Support 3 (S3) 0.30 0.31 0.31
    Support 4 (S4) 0.30